Balanced news tone
News Sentiment
ATH sentiment intelligence
Alterity Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
91/100 classification confidence.
directly relevant articles
high-authority source matches
+21.2% over one week, +20.0% over four weeks, trend active, and materially above fair value.
Here's Why We're Not Too Worried About Alterity Therapeutics' (ASX:ATH) Cash Burn Situation
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Here's Why We're Not Too Worried About Alterity Therapeutics' (ASX:ATH) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 16 Jun 2026 23:17
- Source
- simplywall.st
Alterity Therapeutics Ltd Warrant 2023-31.08.26 on Alterity/Deferred Delivery Statistics – ASX:ATHDB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 13:14
- Source
- TradingView
Alterity Therapeutics (ATHE) completes 1-for-50 share consolidation and trading reset
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
Alterity Consolidates Shares and Temporarily Changes ASX Ticker Ahead of Phase 3 Push
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- The Globe and Mail
Alterity Therapeutics (ASX:ATH) Holds Steady — What Investors Are Watching?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:10
- Source
- Kalkine
Three cities, one MSA program: Alterity lines up May presentations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
StockTake: Alterity Therapeutics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- The Australian
Who’s Who: Alterity Therapeutics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- The Australian
When Can We Expect A Profit From Alterity Therapeutics Limited (ASX:ATH)?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 31 Oct 2025 07:00
- Source
- simplywall.st
We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 31 Aug 2025 07:00
- Source
- Market source
Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Feb 2025 08:00
- Source
- marketscreener.com
Alterity Therapeutics Ltd Company Profile & Introduction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Sep 2024 07:00
- Source
- Moomoo
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jan 2023 08:00
- Source
- PR Newswire
Alterity Therapeutics Limited (ASX: ATH) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2020 03:14
- Source
- intelligentinvestor.com.au
Alterity Therapeutics Limited (ASX:ATH) - Shares, Dividends & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Sep 2019 06:46
- Source
- intelligentinvestor.com.au
Alterity Therapeutics Limited (ASX: ATH) - Announcements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Sep 2019 03:23
- Source
- intelligentinvestor.com.au
ATH Stock Price and Chart — ASX:ATH
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2019 14:39
- Source
- TradingView